Abstract
Cyclooxygenase inhibitors are well known for their anti-inflammatory effects, but recent data indicate that they are also potent anti-angiogenics. The mechanisms by which nonsteroidal anti-inflammatory drugs affect cyclooxygenase enzymes, peptic ulcers, angiogenesis and cancer are complex, but are worth sorting out (pages 1418–1423).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Jones, M.K. et al. Inhibition of angiogenesis by NSAIDs: insight into the mechanisms and implications for cancer growth and ulcer healing. Nature Med. 5, 1418–1423 ( 1999).
Shiff, S.J. & Rigas, B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: Evolving concepts of their chemopreventive actions. Gastroenterology 113, 1992– 1998 (1997).
Shiff, S.J. & Rigas, B. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J. Exp. Med. 190, 445– 450 (1999).
Peterson, H.I. Effects of prostaglandin synthesis inhibitors on tumor growth and vascularization. Experimental studies in the rat. Invasion Metastasis 3, 151–159 (1983).
Tsujii, M. et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 705–716 (1998).
Skopinska-Rózewska, E. et al. Inhibition of angiogenesis by sulindac and its sulfone metabolite (FGN-1): A potential mechanism for their antineoplastic properties. Int. J. of Tissue React. 20, 85–89 (1998).
Mitchell, J.A., Akarasereenont, P., Thiemermann, C., Flower, R.J. & Vane, J.R. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. of the Natl. Acad. Sci. USA 90, 11693– 11697 (1993).
Meade, E.A., Smith, W.L. & DeWitt, D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs. J. Biol. Chem. 268, 6610– 6614 (1993).
Schmassmann, A. et al. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br. J. Pharmacol. 123, 795–804 (1998).
Mizuno, H. et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112, 387–397 (1997).
Fenn, G.C. Controversies in NSAID-induced gastroduodenal damage—do they matter? Aliment. Pharmacol. Ther. 8, 15– 26 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shiff, S., Rigas, B. Aspirin for cancer. Nat Med 5, 1348–1349 (1999). https://doi.org/10.1038/70909
Issue Date:
DOI: https://doi.org/10.1038/70909
This article is cited by
-
ArePlaque angiogenesis and atherosclerosis
Current Atherosclerosis Reports (2001)